Identifying Clinically Relevant Mutations in Somatic NGS Testing

Learn about the challenges and solutions in identifying clinically relevant mutations through Next-Generation Sequencing (NGS) testing in this 43-minute webinar presented by Dr. Ana Krivokuca, founder and Head of the Department for Genetic Counseling at the Institute for Oncology and Radiology of Serbia. Explore how NGS technology enables simultaneous analysis of multiple genomic alterations for precision medicine in cancer care, while addressing the complexities of managing and interpreting the vast amount of genomic data generated. Discover why 50% of U.S. oncologists struggle with NGS result interpretation and why 31% of European small-to-medium labs identify knowledge gaps as a major bottleneck in NGS testing. Gain insights from Dr. Krivokuca's extensive experience in clinical laboratory genetics, variant annotation, and genetic counseling, particularly in breast and ovarian cancer research, supported by her academic background from the University of Belgrade and Clarkson University.